SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decrease in the sales to Rs. 5517.58 millions was observed for the quarter ended December 2025. The sales stood at Rs. 6224.29 millions during the similar quarter previous year.The Company's Net profit for the December 2025 quarter have declined marginally to Rs. 748.26  millions as against Rs. 843.11 millions reported during the corresponding quarter ended.Operating profit surged to 1323.96 millions from the corresponding previous quarter of 1323.73 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 5517.58 6224.29 -11.35 25142.71 24255.67 3.66 30903.69 28325.41 9.10
Other Income 368.15 312.72 17.73 1141.29 880.69 29.59 1194.24 961.23 24.24
PBIDT 1323.96 1323.73 0.02 6463.18 5934.52 8.91 7421.18 5696.10 30.29
Interest 16.60 14.93 11.19 49.65 34.84 42.51 48.68 47.71 2.03
PBDT 1155.50 1308.80 -11.71 6261.67 5899.68 6.14 7372.50 5648.39 30.52
Depreciation 157.93 182.76 -13.59 466.46 476.52 -2.11 632.61 614.92 2.88
PBT 997.57 1126.04 -11.41 5795.21 5423.16 6.86 6739.89 5033.47 33.90
TAX 249.31 282.93 -11.88 1469.92 1387.75 5.92 1720.41 1336.73 28.70
Deferred Tax 5.17 7.54 -31.43 20.13 15.20 32.43 40.46 64.53 -37.30
PAT 748.26 843.11 -11.25 4325.29 4035.41 7.18 5019.48 3696.74 35.78
Equity 4991.46 4991.46 0.00 4991.46 4991.46 0.00 4991.46 4991.46 0.00
PBIDTM(%) 24.00 21.27 12.83 25.71 24.47 5.07 24.01 20.11 19.42

Sumitomo Chemical Share Price

419.25 -17.15 (-3.93%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 642.05
PI Industries 3054.75
Bayer CropScience 4772.40
Sharda Cropchem 1072.05
Sumitomo Chemical 419.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×